Southeast Asia Bispecific Antibodies Market Size & Outlook, 2025-2031
Southeast Asia Bispecific Antibodies Market Size
According to Straits Research analysis, the Southeast Asia Bispecific Antibodies Market was valued at USD 110.24 Million in 2024 and is projected to reach USD 312.46 Million by 2031, expanding at a CAGR of 16.9% during the forecast period. This promising growth is primarily driven by the burgeoning demand in therapeutic treatment of diseases such as cancer and infectious diseases. Key drivers include the escalating prevalence of malignant diseases and the rapid surge in biopharmaceutical researches, especially in the oncology sector. Emerging trends, such as technological advancements in Antibody-drug conjugates (ADCs) and the rise in adoption of targeted therapies, provide significant growth opportunities. With efforts towards boosting native biotech industries and improving healthcare infrastructure, Southeast Asia is positioning itself as a lucrative market for bispecific antibodies in the coming years.
Source: Straits Research Analysis Company Publications, Primary Interviews.
Southeast Asia Bispecific Antibodies Market Highlights
- Bi-specific T-cell engager held the leading position among Type segments in 2024, based on market size.
- Bi-specific T-cell engager is projected to post the fastest growth rate, sustaining its position as the most attractive Type segment during the forecast horizon.
- In 2024, Southeast Asia represented 2% of the overall global bispecific antibodies market size.
- United States is projected to lead the global bispecific antibodies market size by 2031.
- Across Asia Pacific, China is anticipated to hold the dominant position in market by 2031.
- India is forecasted to expand at the fastest pace in Asia Pacific, attaining USD 454.85 Million by 2031.
- 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
- 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2031 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2031 |
| Market Size In 2024 | USD 110.24 Million |
| Market Size In 2031 | USD 312.46 Million |
| Largest segment | Bi-specific T-cell engager |
| Fastest segment | Bi-specific T-cell engager |
| Units | Revenue in USD Million |
| CAGR | 16.9% (2025-2031) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Southeast Asia Bispecific Antibodies Market Share By Type
Segmentation Covered
| Segments | Sub Segments |
|---|---|
| Type |
|
| Therapeutic Areas |
|
| Target |
|
Southeast Asia Bispecific Antibodies Market By Type 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
Southeast Asia Bispecific Antibodies Market By Therapeutic Areas 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
Southeast Asia Bispecific Antibodies Market By Target 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
